Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Digital measures of respiratory and upper limb function in spinal muscular atrophy: design, feasibility, reliability, and preliminary validity of a smartphone sensor-based assessment suite.
Perumal TM, Wolf D, Berchtold D, Pointeau G, Zhang YP, Cheng WY, Lipsmeier F, Sprengel J, Czech C, Chiriboga CA, Lindemann M; JEWELFISH Working Group. Perumal TM, et al. Among authors: cheng wy. Neuromuscul Disord. 2023 Nov;33(11):845-855. doi: 10.1016/j.nmd.2023.07.008. Epub 2023 Aug 25. Neuromuscul Disord. 2023. PMID: 37722988 Free article.
Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
Lipsmeier F, Taylor KI, Kilchenmann T, Wolf D, Scotland A, Schjodt-Eriksen J, Cheng WY, Fernandez-Garcia I, Siebourg-Polster J, Jin L, Soto J, Verselis L, Boess F, Koller M, Grundman M, Monsch AU, Postuma RB, Ghosh A, Kremer T, Czech C, Gossens C, Lindemann M. Lipsmeier F, et al. Among authors: cheng wy. Mov Disord. 2018 Aug;33(8):1287-1297. doi: 10.1002/mds.27376. Epub 2018 Apr 27. Mov Disord. 2018. PMID: 29701258 Free PMC article. Clinical Trial.
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.
Lipsmeier F, Taylor KI, Postuma RB, Volkova-Volkmar E, Kilchenmann T, Mollenhauer B, Bamdadian A, Popp WL, Cheng WY, Zhang YP, Wolf D, Schjodt-Eriksen J, Boulay A, Svoboda H, Zago W, Pagano G, Lindemann M. Lipsmeier F, et al. Among authors: cheng wy. Sci Rep. 2022 Jul 15;12(1):12081. doi: 10.1038/s41598-022-15874-4. Sci Rep. 2022. PMID: 35840753 Free PMC article.
Automatic speaker diarization for natural conversation analysis in autism clinical trials.
O'Sullivan J, Bogaarts G, Schoenenberger P, Tillmann J, Slater D, Mesgarani N, Eule E, Kilchenmann T, Murtagh L, Hipp J, Lindemann M, Lipsmeier F, Cheng WY, Nobbs D, Chatham C. O'Sullivan J, et al. Among authors: cheng wy. Sci Rep. 2023 Jun 24;13(1):10270. doi: 10.1038/s41598-023-36701-4. Sci Rep. 2023. PMID: 37355730 Free PMC article.
Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies.
Dziadek S, Kraxner A, Cheng WY, Ou Yang TH, Flores M, Theiss N, Tsao TS, Andersson E, Harring SV, Bröske AE, Ceppi M, Teichgräber V, Charo J. Dziadek S, et al. Among authors: cheng wy. Front Immunol. 2024 Mar 15;15:1352615. doi: 10.3389/fimmu.2024.1352615. eCollection 2024. Front Immunol. 2024. PMID: 38558814 Free PMC article.
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study.
Huntington SF, Cheng WY, Sarpong EM, Leng S, Farooqui MZH, Agu US, Catillon M, Lejeune D, Downes N, Matay L, Duh MS, De Nigris E. Huntington SF, et al. Among authors: cheng wy. Leuk Lymphoma. 2024 May 2:1-11. doi: 10.1080/10428194.2024.2331631. Online ahead of print. Leuk Lymphoma. 2024. PMID: 38696747
328 results